Professor, Internal Medicine, University of Missouri, Kansas City School of Medicine
Cardiology
Dr. Barry D. Rutherford, MD
|
|
Give Review
Barry D. Rutherford, MD works in the field of Cardiology. He studied medicine at University of Otago School of Medicine. He has 4 awards "CMS Meaningful Use Stage 1 Certification", "Super Doctor", "Whos Who in Medicine and Healthcare" and "Fellow (FACC)". Dr. Barry D. Rutherford is also published. He has 15 publications published. The lastest publication: "Search for Top Squarks in R-Parity-Violating Supersymmetry Using Three or More Leptons and b-Tagged Jets.' Barry Rutherford accepts Medicare payments and is listed with Medicare.gov.
Publications
- Search for Top Squarks in R-Parity-Violating Supersymmetry Using Three or More Leptons and b-Tagged Jets.
- Changes in myocardial ischemic burden following percutaneous Coronary intervention of chronic total occlusions.
- Chronic total occlusion angioplasty in the United States.
- Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in Acute myocardial infarction: results from the CADILLAC trial.
- Improvement in survival following successful percutaneous Coronary intervention of Coronary chronic total occlusions: variability by target vessel.
- Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation Acute myocardial infarction with versus without ...
- Usefulness of routine unfractionated heparin infusion following primary percutaneous coronary intervention for Acute myocardial infarction in patients not receiving gl...
- Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for Acute myocardial infarction.
- Outcomes of patients consented but not randomized in a trial of primary percutaneous coronary intervention in Acute myocardial infarction (the CADILLAC registry).
- Impact of smoking status on outcomes of primary coronary intervention for Acute myocardial infarction--the smoker's paradox revisited.
- Multivessel percutaneous coronary intervention in patients with multivessel disease and Acute myocardial infarction.
- Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for Acute myocardial infarction.
- Improving in-hospital mortality in the setting of an increasing risk profile among patients undergoing catheter-based reperfusion for an Acute myocardial infarction wi...
- Diabetes mellitus is associated with a shift in the temporal risk profile of inhospital death after percutaneous Coronary intervention: an analysis of 25,223 patients ...
Schools
University Of Otago School Of Medicine
Dunedin Public Hospital Otago M
Mayo Grad School MedMayo Fndn
University of Utah
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Whos Who in Medicine and Healthcare
- Fellow (FACC)
Education
-
Mayo School of Graduate Medical Education -
University of Otago School of Medicine
Drug Facts
| NPI NUMBER | 1396701066 | |
| NPPES Provider LastName | RUTHERFORD | |
| NPPES Provider FirstName | BARRY | |
| NPPES Provider ZIPCode | 641115939 | |
| NPPES Provider State | MO | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1141.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1396701066 |
| Last Name Of The Provider | RUTHERFORD |
| First Name Of The Provider | BARRY |
| View All |